Randolph Michael, Tosti Antonella
Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, Florida.
Dr Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, Florida.
J Am Acad Dermatol. 2021 Mar;84(3):737-746. doi: 10.1016/j.jaad.2020.06.1009. Epub 2020 Jul 2.
Although topical minoxidil is an effective treatment option for hair loss, many patients are poorly compliant because of the necessity to apply the medication twice a day, undesirable hair texture, and scalp irritation.
In recent years, oral minoxidil at low dose has been proposed as a safe alternative. This study reviewed articles in which oral minoxidil was used to treat hair loss to determine its efficacy and safety as an alternative to topical minoxidil.
PubMed searches were performed to identify articles discussing oral minoxidil as the primary form of treatment for hair loss published up to April 2020.
A total of 17 studies with 634 patients were found discussing the use of oral minoxidil as the primary treatment modality for hair loss. Androgenetic alopecia was the most studied condition, but other conditions included telogen effluvium, lichen planopilaris, loose anagen hair syndrome, monilethrix, alopecia areata, and permanent chemotherapy-induced alopecia.
Larger randomized studies comparing the efficacy/safety of different doses with standardized objective measurements will be needed to clarify the best treatment protocol.
Oral minoxidil was found to be an effective and well-tolerated treatment alternative for healthy patients having difficulty with topical formulations.
尽管外用米诺地尔是治疗脱发的一种有效选择,但由于需要每天用药两次、不理想的头发质地和头皮刺激,许多患者的依从性较差。
近年来,低剂量口服米诺地尔已被提议作为一种安全的替代方案。本研究回顾了使用口服米诺地尔治疗脱发的文章,以确定其作为外用米诺地尔替代方案的有效性和安全性。
在PubMed上进行检索,以识别截至2020年4月发表的将口服米诺地尔作为脱发主要治疗形式进行讨论的文章。
共发现17项研究,涉及634例患者,讨论了将口服米诺地尔作为脱发的主要治疗方式。雄激素性脱发是研究最多的病症,但其他病症包括休止期脱发、扁平苔藓性秃发、生长期松动综合征、念珠状发、斑秃和永久性化疗引起的脱发。
需要更大规模的随机研究,通过标准化的客观测量比较不同剂量的有效性/安全性,以明确最佳治疗方案。
对于外用制剂使用困难的健康患者,口服米诺地尔是一种有效且耐受性良好的治疗替代方案。